Clinical trial
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients
NCT00364052 · Oregon Health and Science University, Other · Unknown status
Key facts
| NCT number | NCT00364052 |
|---|---|
| Title | Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients |
| Official title | Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients: A Single Center Experience With Oral Ganciclovir Versus Valganciclovir |
| Lead sponsor | Oregon Health and Science University, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | oral Valganciclovir vs oral Ganciclovir |
| Enrollment | 200 |
| Start date | Aug 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Aug 15, 2006 |
| Last update posted | Aug 17, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: